Charlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...
Read moreBack in January this year, we summarised the key trends our market access experts believed would dom...
Read moreSwitzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...
Read moreConduct a rapid pricing and market access (P&MA) assessment across the US and EU5 in order to determ...
Read moreOur client wanted to gain an understanding of payer willingness to pay and determine the likely clin...
Read moreOur client wanted to understand the clinical and economic evidence requirements that drive payer dec...
Read moreWe explore what the joint clinical assessment (JCA) is, its process and what future developments may...
Read morePayer value proposition development and understanding evidence requirements to secure pricing and re...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreAll other aspects of the voluntary scheme remain unchanged.
Read more